January 2019 FDA Recall Clobetasol Propionate by Oxalis Labs
D-0492-2019 - Defective Container; complaints of leakage.

This Class III drug recall was voluntarily initiated by Oxalis Labs on January 11, 2019 for the product Clobetasol Propionate. The FDA reported the reason for recall as defective container; complaints of leakage.. The product was distributed in Product was distributed to 4 major distributors in IL, NY, AR, KY who may have further distribute the product throughout the United States. and the recall is currently terminated.

Recall Number: D-0492-2019

Reason for Recall
Defective Container; complaints of leakage.
Initiated
01-11-2019
Reported
02-20-2019
Quantity
53,358 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Product was distributed to 4 major distributors in IL, NY, AR, KY who may have further distribute the product throughout the United States.
Clobetasol Propionate Topical Solution USP, 0.05% w/w, 50 mL bottle, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536 Manufacturer: Macleods Pharmaceuticals Ltd Al Oxalis Labs Baddi Himachal Pradesh INDIA, UPC Code 33342032186 ---- NDC 33342-321-86

Batch or Lot Expiration Information

Lot# Lot Numbers: PCA801A, PCA802A, PCA803A, exp. date 12/2019; PCA804A, PCA805A, PCA806A, PCA807A, exp. date 04/2020